Lethal toxicity of uracil/tegafur in the treatment of sigmoid carcinoma

被引：5

作者：

Bosch, T. M. ^{[1
]}

Meijerman, I.

Beijnen, J. H.

van Thiel, S. W.

Vlasveld, L. T.

机构：

[1] Slotervaart Hosp, Netherlands Canc Inst, Dept Pharm & Pharmacol, Amsterdam, Netherlands

[2] Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Utrecht, Netherlands

[3] Bronovo Hosp, Dept Internal Med, The Hague, Netherlands

来源：

ANNALS OF ONCOLOGY | 2007年 / 18卷 / 03期

关键词：

D O I：

10.1093/annonc/mdl432

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 5 条

[1]

Akay S, 2004, Expert Opin Drug Saf, V3, P89, DOI 10.1517/14740338.3.2.89

[2]

Kajita Jiro, 2003, Drug Metab Pharmacokinet, V18, P303, DOI 10.2133/dmpk.18.303

[3] Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer [J].

Kim, DJ ;

Kim, TI ;

Suh, JH ;

Cho, YS ;

Shin, SK ;

Kang, JK ;

Kim, NK ;

Kim, WH .

YONSEI MEDICAL JOURNAL, 2003, 44 (04) :665-675

[4] Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene:: Impairment of its promoter activity [J].

Pitarque, M ;

von Richter, O ;

Oke, B ;

Berkkan, H ;

Oscarson, M ;

Ingelman-Sundberg, M .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 284 (02) :455-460

[5] Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro [J].

Yoshida, R ;

Nakajima, M ;

Nishimura, K ;

Tokudome, S ;

Kwon, JT ;

Yokoi, T .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (01) :69-76

← 1 →